Personal Information
Organization / Workplace
Thanjavur Area, India India
Occupation
associate professor of medical oncology at regional cancer center kancheepuram
Tags
oncology geriatrics
oncology geriatrics
See more
Documents
(3)Likes
(458)The Future of Antiangiogenic Therapies in Ovarian Cancer: A Series of Community and Academic Grand Rounds
Institute For Medical Education and Research (IMER)
•
11 years ago
Immunotherapy: an old dogma and evolving insight
Mohamed Abdulla
•
7 years ago
Challenges in managing adverse effects of immunotherapy treatment
SCGH ED CME
•
6 years ago
Revisiting PD-L1 as an Immunotherapy Biomarker Across the Cancer Spectrum: Current and Emerging Standards of Testing, Scoring, and Assay Interpretation
PVI, PeerView Institute for Medical Education
•
2 years ago
Maximizing the Benefits and Minimizing the Risks of Cancer Immunotherapies in Everyday Oncology Practice: Need-to-Know Information and Practical Guidance for Oncology Nurses
PVI, PeerView Institute for Medical Education
•
4 years ago
Patient perspective on immune oncology
LungCancerEU
•
6 years ago
Imugene Corporate Presentation
RedChip Companies, Inc.
•
8 years ago
IO Landscape Analysis - JPM18 - Aiman Shalabi
Arsalan Arif
•
6 years ago
Basic principles of cancer immunotherapy
Mohamed Abdulla
•
5 years ago
BioSci - IO Alliances
Mark Edwards
•
5 years ago
Cancer immunotherapy different modes of action - astra zeneca - jordan
Mohamed Abdulla
•
6 years ago
Taking Immunotherapy to the Next level
Company Spotlight
•
7 years ago
Gaining Confidence in Predicting and Assessing Response to Cancer Immunotherapies: Practical Strategies for Biomarker Testing and Pathologic Response Assessment
PVI, PeerView Institute for Medical Education
•
1 year ago
Refining Best Practices in Cancer Immunotherapy Biomarker Testing and Pathologic Response Assessment
PVI, PeerView Institute for Medical Education
•
1 year ago
Leveraging Neoadjuvant and Adjuvant Immunotherapy to Break Through the Outcomes Plateau, Prevent Recurrences, and Improve Curability in Early-Stage Cancers
PVI, PeerView Institute for Medical Education
•
2 years ago
Making the Most of the New Era of Immuno-Oncology in TNBC: Essential Guidance for Surgeons on How to Maximize the Potential of Immunotherapies and Combinations in Advanced and Early-Stage Breast Cancer
PVI, PeerView Institute for Medical Education
•
3 years ago
On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum
PVI, PeerView Institute for Medical Education
•
4 years ago
On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum
PVI, PeerView Institute for Medical Education
•
4 years ago
Expanding Precision Medicine & Biomarker Strategy Options with RNAscope
William Baird
•
6 years ago
Optimizing Patient Outcomes in RCC Through Safe and Efficacious Use of Immuno-Oncology and Targeted Approaches: Teaming Up to Mitigate and Manage Adverse Events and Maximize Survival
PVI, PeerView Institute for Medical Education
•
3 years ago
The Era of Immuno-Oncology in TNBC: Navigating Evidence in Early-Stage and Advanced Disease, Practicalities of Integration, and Implications for Breast Surgeons
PVI, PeerView Institute for Medical Education
•
3 years ago
Beyond the Basics of Immuno-Oncology: Navigating Clinical Challenges to Maximize the Benefits and Minimize the Risks of Cancer Immunotherapies
PVI, PeerView Institute for Medical Education
•
4 years ago
Keeping Up With Advances in Cancer Immunotherapy and Biomarker Testing: Implications for Pathologists at the Forefront of the Emerging Precision Immuno-Oncology Era
PVI, PeerView Institute for Medical Education
•
5 years ago
The Central Role of Biomarker Testing in Piecing Together the Immuno-Oncology Puzzle: Essential Guidance for Pathologists to Maximize the Potential of Cancer Immunotherapies
PVI, PeerView Institute for Medical Education
•
5 years ago
Tumor Mutational Load assessment of FFPE samples using an NGS based assay
Thermo Fisher Scientific
•
6 years ago
RATIONAL COMBINATION IMMUNOTHERAPY: The best of ASCO16 clinical data
Paul D. Rennert
•
7 years ago
HealthBIO 2021_Cancer I/O Translating immuno-oncology into health actions_Jeroen Pouwels
Business Turku
•
2 years ago
Emergency Department on Alert: Solving Oncologic Emergency Quandaries During the Immuno-Oncology Era and COVID-19 Pandemic
PVI, PeerView Institute for Medical Education
•
3 years ago
Advancing the Management of Urothelial Cancer With Immuno-Oncology and Targeted Approaches: Key Concepts for Urology Professionals on the Front Lines of Care
PVI, PeerView Institute for Medical Education
•
4 years ago
Expanding Options and Difficult Choices in the Initial Treatment of Advanced NSCLC: How to Personalize Treatment Decisions in the Era of Immuno-Oncology and Combinations
PVI, PeerView Institute for Medical Education
•
5 years ago
Personal Information
Organization / Workplace
Thanjavur Area, India India
Occupation
associate professor of medical oncology at regional cancer center kancheepuram
Tags
oncology geriatrics
oncology geriatrics
See more